Enanta Pharmaceuticals, Inc. (ENTA)
14.13
+0.04
(+0.28%)
USD |
NASDAQ |
Sep 03, 12:17
Enanta Pharmaceuticals Price : 14.13 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 13.56 | 14.19 | 13.48 | 14.09 | 251784.0 |
| Sep 01, 2026 | 13.34 | 13.64 | 13.24 | 13.51 | 217296.0 |
| Aug 31, 2026 | 13.52 | 13.60 | 13.12 | 13.33 | 286516.0 |
| Aug 28, 2026 | 13.72 | 13.91 | 13.47 | 13.60 | 155915.0 |
| Aug 27, 2026 | 14.08 | 14.18 | 13.76 | 13.80 | 280234.0 |
| Aug 26, 2026 | 14.00 | 14.37 | 13.75 | 14.15 | 156203.0 |
| Aug 25, 2026 | 14.06 | 15.05 | 14.02 | 14.08 | 407079.0 |
| Aug 24, 2026 | 13.44 | 14.27 | 12.83 | 14.10 | 357439.0 |
| Aug 21, 2026 | 13.27 | 13.70 | 13.09 | 13.47 | 335246.0 |
| Aug 20, 2026 | 13.42 | 13.50 | 12.93 | 13.13 | 194821.0 |
| Aug 19, 2026 | 13.51 | 13.63 | 13.16 | 13.51 | 187392.0 |
| Aug 18, 2026 | 12.80 | 13.42 | 12.80 | 13.30 | 196630.0 |
| Aug 17, 2026 | 13.13 | 13.32 | 12.59 | 12.83 | 314792.0 |
| Aug 14, 2026 | 13.38 | 13.40 | 12.96 | 13.16 | 173405.0 |
| Aug 13, 2026 | 13.57 | 13.98 | 13.44 | 13.44 | 152715.0 |
| Aug 12, 2026 | 13.48 | 13.68 | 13.27 | 13.50 | 149824.0 |
| Aug 11, 2026 | 13.74 | 13.82 | 12.71 | 13.52 | 200171.0 |
| Aug 10, 2026 | 13.73 | 13.86 | 13.64 | 13.81 | 147586.0 |
| Aug 07, 2026 | 13.43 | 13.87 | 13.35 | 13.77 | 182991.0 |
| Aug 06, 2026 | 13.27 | 13.54 | 13.19 | 13.34 | 220703.0 |
| Aug 05, 2026 | 13.40 | 13.68 | 13.03 | 13.22 | 230045.0 |
| Aug 04, 2026 | 13.05 | 13.63 | 12.71 | 13.32 | 209591.0 |
| Aug 03, 2026 | 12.70 | 12.97 | 12.34 | 12.95 | 168148.0 |
| Jul 31, 2026 | 12.73 | 12.99 | 12.50 | 12.60 | 143719.0 |
| Jul 30, 2026 | 12.42 | 13.02 | 12.32 | 13.00 | 142363.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 3.10 |
| AbbVie, Inc. | 260.74 |
| Coherus Oncology, Inc. | 1.385 |
| BridgeBio Pharma, Inc. | 75.79 |
| RenovoRx, Inc. | 2.21 |
Price Related Metrics
| PS Ratio | 5.860 |
| Price to Book Value | 4.071 |
| Earnings Yield | -17.06% |
| Market Cap | 411.47M |